Table 4 Usual practice when seeing patients with or without prodromal AD/MCI due to AD
From: Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
Never | Rarely | Sometimes | Routinely | p value* | ||
|---|---|---|---|---|---|---|
Patient counseling | ||||||
- Diet and nutrition | Prodromal AD | 7 (11) | 5 (8) | 25 (38) | 28 (43) | 0.97 |
No prodromal AD | 8 (12) | 6 (9) | 24 (37) | 27 (42) | ||
- Vitamins | Prodromal AD | 15 (23) | 19 (29) | 23 (35) | 8 (12) | 0.99 |
No prodromal AD | 14 (22) | 19 (29) | 24 (37) | 8 (12) | ||
- Mental exercise | Prodromal AD | 2 (3) | 2 (3) | 7 (10) | 56 (84) | 0.45 |
No prodromal AD | 3 (4) | 5 (8) | 10 (15) | 48 (73) | ||
- Physical exercise | Prodromal AD | 1 (1) | 1 (1) | 10 (15) | 55 (82) | 0.31 |
No prodromal AD | 1 (2) | 4 (6) | 15 (23) | 46 (69) | ||
- Alcohol | Prodromal AD | 10 (15) | 13 (20) | 22 (33) | 21 (32) | 0.95 |
No prodromal AD | 8 (13) | 12 (19) | 24 (38) | 20 (30) | ||
Patient education | ||||||
- Advance planning | Prodromal AD | 0 | 6 (9) | 28 (41) | 34 (50) | 0.0001* |
No prodromal AD | 6 (9) | 20 (30) | 26 (39) | 14 (21) | ||
- Driving | Prodromal AD | 0 | 5 (7) | 27 (40) | 36 (53) | 0.0001* |
No prodromal AD | 5 (8) | 18 (27) | 28 (42) | 15 (23) | ||
- Research studies | Prodromal AD | 0 | 5 (7) | 32 (47) | 31 (46) | 0.0001* |
No prodromal AD | 6 (9) | 25 (38) | 26 (39) | 9 (14) | ||
- Support services | Prodromal AD | 0 | 11 (16) | 24 (36) | 32 (48) | 0.003* |
No prodromal AD | 4 (6) | 25 (38) | 19 (29) | 18 (27) | ||
- Recommendations for follow-up | Prodromal AD | 0 | 2 (3) | 4 (6) | 61 (91) | 0.0001* |
No prodromal AD | 0 | 10 (15) | 15 (22) | 42 (63) | ||
- Risk of AD and related disorder (general terms) | Prodromal AD | 0 | 1 (2) | 23 (34) | 42 (64) | 0.0001* |
No prodromal AD | 3 (5) | 17 (27) | 22 (34) | 22 (34) | ||
- Risk of related disorders (numeric estimates) | Prodromal AD | 9 (13) | 19 (28) | 27 (40) | 12 (18) | 0.33 |
No prodromal AD | 13 (20) | 24 (38) | 19 (30) | 8 (12) | ||
- Referral to Alzheimer’s association or similar organization | Prodromal AD | 6 (9) | 16 (24) | 30 (46) | 14 (21) | 0.0001* |
No prodromal AD | 29 (45) | 20 (31) | 12 (18) | 4 (6) | ||
- Written summary letter of findings for patient and family | Prodromal AD | 6 (9) | 6 (9) | 18 (27) | 37 (55) | 0.91 |
No prodromal AD | 6 (9) | 8 (12) | 19 (29) | 33 (50) | ||
Medication prescribed | ||||||
- Cholinesterase inhibitors | Prodromal AD | 9 (13) | 8 (12) | 26 (39) | 24 (36) | 0.0001* |
No prodromal AD | 40 (61) | 18 (27) | 6 (9) | 2 (3) | ||
- Memantine | Prodromal AD | 44 (66) | 13 (19) | 7 (11) | 3 (4) | 0.30 |
No prodromal AD | 52 (79) | 10 (15) | 3 (4) | 1 (2) | ||
- Other | Prodromal AD | 12 (32) | 5 (13) | 16 (42) | 5 (13) | 0.46 |
No prodromal AD | 13 (37) | 2 (6) | 18 (51) | 2 (6) | ||